These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1329248)

  • 1. Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy with carboplatin, etoposide and epirubicin.
    Nyman CR
    Thorax; 1992 Aug; 47(8):668. PubMed ID: 1329248
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.
    Collard P; Weynants P; Francis C; Rodenstein DO
    Thorax; 1992 May; 47(5):369-71. PubMed ID: 1319088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
    Gridelli C; Perrone F; D'Aprile M; Rossi A; Palmeri S; Curcio C; Veltri E; Ianniello G; Lorusso V; Palmieri G
    Eur J Cancer; 1995 Dec; 31A(13-14):2424-6. PubMed ID: 8652288
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer.
    Gridelli C; Ianniello GP; Maiorino A; Curcio C; D'Aprile M; Brancaccio L; Palmeri S; Gentile M; Comella G; Pedicini T
    Am J Clin Oncol; 1994 Apr; 17(2):160-2. PubMed ID: 8141108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin/etoposide in small cell lung cancer.
    Bishop JF
    Oncology; 1992; 49 Suppl 1():11-7; discussion 17-8. PubMed ID: 1323807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose intensification of carboplatin and etoposide as first-line combination chemotherapy in small cell lung cancer.
    Ellis PA; Talbot DC; Priest K; Jones AL; Smith IE
    Eur J Cancer; 1995 Oct; 31A(11):1888-9. PubMed ID: 8541123
    [No Abstract]   [Full Text] [Related]  

  • 8. Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.
    Humblet Y; Weynants P; Bosly A; Majois F; Duprez P; Francis C; Beauduin M; Machiels J; Gailly C; Delaunois L
    Med Oncol Tumor Pharmacother; 1989; 6(3):207-12. PubMed ID: 2559261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
    Gridelli C; Curcio C; Iaffaioli RV; Brancaccio L; D'Aprile M; Gebbia V; Rossi A; Tortoriello A; Veltri E; Maione P; Barbarisi A; Gallo C; Guida C; Perrone F
    Anticancer Res; 2001; 21(6A):4179-83. PubMed ID: 11911315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Carboplatin replace Cisplatin in small cell lung cancer?
    Noronha V
    Indian J Cancer; 2011; 48(4):452-3. PubMed ID: 22293259
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
    Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on "carboplatin-etoposide association in small cell lung cancer patients older than 70 years: a phase II trial".
    Murray N
    Lung Cancer; 2002 Jan; 35(1):9-10. PubMed ID: 11750706
    [No Abstract]   [Full Text] [Related]  

  • 13. Modified Ifosphamide/CarboPlatin/Etoposide.
    Snee MP
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):165; author reply 165. PubMed ID: 12801057
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Le Péchoux C; Arriagada R; Le Chevalier T
    Cancer; 1995 Aug; 76(3):530-1. PubMed ID: 8625139
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of broncho-pulmonary cancer using carboplatin/etoposide: survival analysis].
    Skaventzos I; Weber T; Bury T; Radermecker MF
    Rev Med Liege; 1996 Nov; 51(11):718-20. PubMed ID: 9011926
    [No Abstract]   [Full Text] [Related]  

  • 18. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
    Kosmidis PA; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):23-30. PubMed ID: 8052870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for elderly SCLC patients.
    Satoh H; Ohtsuka M; Sekizawa K
    Lung Cancer; 2003 Apr; 40(1):107. PubMed ID: 12660016
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide].
    Tassinari D; Genestreti G; Pasquini E; Fantini M; Poggi B; Tamburini E; Papi M; Ioli G; Oliverio G; Fochessati F; Arcangeli V; Agostini V; Mianulli AM; Imola M; Fattori PP; Ravaioli A
    Recenti Prog Med; 2005 May; 96(5):234-9. PubMed ID: 15977652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.